Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.
Emerging results suggest that ceramides with different fatty acid chain lengths might play distinct functions in the regulation of tumor growth and therapy. Here we report that de novo-generated C(18)- and C(16)-ceramides by ceramide synthases 1 and 6 (CerS1 and CerS6) play opposing proapoptotic and prosurvival roles, respectively, in human head and neck squamous cell carcinomas (HNSCCs). Unexpectedly, knockdown of CerS6/C(16)-ceramide using small interfering RNA induced endoplasmic reticulum (ER)-stress-mediated apoptosis. Reconstitution of C(16)-ceramide generation by induced expression of wild-type CerS6, but not its catalytically inactive mutant, protected cells from cell death induced by knockdown of CerS6. Moreover, using molecular tools coupled with analysis of sphingolipid metabolism showed that generation of C(16)-ceramide, and not dihydro-C(16)-ceramide, by induced expression of CerS6 rescued cells from ER stress and apoptosis. Mechanistically, regulation of ER-stress-induced apoptosis by CerS6/C(16)-ceramide was linked to the activation of a specific arm, ATF6/CHOP, of the unfolded protein response pathway. Notably, while expression of CerS1/C(18)-ceramide inhibited HNSCC xenograft growth, CerS6/C(16)-ceramide significantly protected ER stress, leading to enhanced tumor development and growth in vivo, consistent with their pro- and antiapoptotic roles, respectively. Thus, these data reveal an unexpected and novel prosurvival role of CerS6/C(16)-ceramide involved in the protection against ER-stress-induced apoptosis and induction of HNSCC tumor growth.
Senkal
Can E
CE
Hollings Cancer Center, 86 Jonathan Lucas Street, Charleston, SC 29425, USA.
Ponnusamy
Suriyan
S
Bielawski
Jacek
J
Hannun
Yusuf A
YA
Ogretmen
Besim
B
D051702:Activating Transcription Factor 6 / Q000378:metabolism*; D017209:Apoptosis / Q000502:physiology*; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D002518:Ceramides / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006258:Head and Neck Neoplasms / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D051049:Sphingosine N-Acyltransferase; D013312:Stress, Physiological; D051742:Transcription Factor CHOP / Q000378:metabolism*; D056811:Unfolded Protein Response
C497111:ATF6 protein, human; D051702:Activating Transcription Factor 6; D002518:Ceramides; C497249:DDIT3 protein, human; D008565:Membrane Proteins; D034741:RNA, Small Interfering; D011994:Recombinant Proteins; D051742:Transcription Factor CHOP; C097760:N-palmitoylsphingosine; D010088:Oxidoreductases; C108138:dihydroceramide desaturase; C506123:CERS6 protein, human; D051049:Sphingosine N-Acyltransferase